Hugging Face is launching a new AI model that lets scientists 'chat with DNA'Business Insider · 3 days ago
Cerenome Announces New Dual Mechanism of Action Featuring Lethal DNA Damage and Beneficial Immunomodulation Supporting Lead Investigational Drug REYOBIQ™GlobeNewsWire · 4 days ago
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research · 5 days ago
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader MarketZacks Investment Research · Oct 14, 2026
What's Going on With Ginkgo Bioworks Stock on Friday?Benzinga · Oct 9, 2026
Araceli Biosciences und Ginkgo Bioworks ermöglichen die zelluläre Bildgebung in großem Maßstab für das „Lab-in-the-Loop"-System von NebulaPRNewsWire · Oct 8, 2026Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 5, 2026 | -$0.90 | -$0.75 | Beat |
| May 7, 2026 | -$1.21 | -$1.39 | Miss |
| Feb 26, 2026 | -$1.80 | -$1.42 | Beat |
| Nov 6, 2025 | -$1.24 | -$1.45 | Miss |
| Aug 7, 2025 | -$1.44 | -$1.10 | Beat |
| May 6, 2025 | -$1.23 | -$1.68 | Miss |